Please assess the completion status of the following clinical trial:

Trial Title: Digital Therapeutic vs Educational App for Depression Among Adolescents

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Be 13-17.5 years of age~2. Be a U.S. Resident~3. Able to read and write in English~4. If currently on medication: regular, stable dose of antidepressant medications (e.g., escitalopram/Lexapro, fluoxetine/Prozac) for at least 60 days at screening~5. If currently receiving psychotherapy: must be in therapy for at least 4 weeks at screening~6. Own or have regular access to a smartphone (operating systems: Android 6 or later and iOS 13 or later) that can receive SMS messages, and has reliable Wi-Fi access or sufficient data to engage with study app~7. Available and committed to engage with the program for a 8-week duration and complete assessments~8. Participants must be able to understand and willing to provide informed assent and to comply with all study procedures and restrictions~9. Willingness to provide parent/guardian contact information to provide eConsent and participate in clinical interviews~Exclusion Criteria:~1. PHQ-A score less than 10~2. Lifetime diagnosis of a psychotic disorder (including schizophrenia or schizoaffective disorder)~3. Lifetime diagnosis of bipolar disorder~4. Lifetime diagnosis of autism spectrum disorder or pervasive developmental disorder (e.g., Asperger syndrome, Rett's syndrome, or pervasive developmental disorder not otherwise specified)~5. Current (past year) diagnosis of a substance use disorder~6. Suicide attempt or suicidal ideation with plan and intent within the past 12 months~7. Previous Woebot application use~8. Enrollment of more than one member of the same household

- Gender: ALL
- Minimum Age: 13 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- W-GenZD Mobile Application Group (Type: EXPERIMENTAL): Participants assigned to the W-GenZD mobile application group will be asked to download and use the W-GenZD mobile application that will provide information and tools through a chatbot (a computer program designed to communicate with users). Participants will be invited to use the mobile application as often as they like during the 4-week treatment period - we will encourage 5 to 10 minutes of daily use.
- Digital Education Application Group (Type: SHAM_COMPARATOR): Participants assigned to the Digital Education mobile app group will be given instructions on how to download and access the application that will provide general health information. A new article will be provided to the participant at a rate of once per week across the 4 weeks (4 articles total) and they will receive a weekly notification when a new article is available. Each article will be available for one week from release date. We expect a target dosage of roughly 30 minutes per week (120 min), which would make it comparable to Woebot (about 5 min per day X 28 days = 140 min).

Based on this trial design, predict the completion outcome and termination type (if applicable).